Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
[Urinary tract infection caused by Candida while using an SGLT-2 inhibitor].
Anna M Zeelenberg1,2, Gerard J van der Wielen1, Edith D Beishuizen3
1Haaglanden Medisch Centrum, afd. Urologie, Den Haag.
Sodium glucose transporter 2 (SGLT-2) inhibitors can cause glucosuria, increasing the risk of urinary tract infections. A case study showed a patient’s Candida glabrata infection resolved after discontinuing SGLT-2 inhibitor therapy.
Area of Science:
- Nephrology
- Endocrinology
- Infectious Diseases
Background:
- Sodium glucose transporter 2 (SGLT-2) inhibitors are a novel class of antidiabetic medications.
- These drugs function by inhibiting renal glucose reabsorption, leading to glucosuria.
- SGLT-2 inhibitors are increasingly prescribed due to their demonstrated nephrological and cardiovascular benefits.
More Related Videos
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection II: Pathophysiology
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management

